CLINICAL_TRIALS
trial_result
· 2020-03-24
Clinical Trial Update: A Study of LY2228820 in Participants With Advanced Cancer [Phase 1]
Summary
Phase 1 study of LY2228820 in participants with advanced cancer has completed; results were posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED | Results posted: 2020-03-24